Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?
- PMID: 8901770
Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?
Abstract
Background: Unlike skeletal myocytes, mammalian adult cardiomyocytes cannot regenerate after injury. A possible strategy to increase viability and augment ventricular function after myocardial injury is fetal myocardial tissue transplantation. The engrafted fetal cells are a potential source of growth factors and can be used for cardiomyocyte-based gene therapy. The purpose of our study was to test the feasibility and efficiency of fetal cardiomyocyte transplantation into a model of myocardial infarction.
Methods and results: We subjected rats after myocardial infarction to three protocols of therapy. In the first protocol, tissue fragments of cultured human fetal ventricles were injected into the scar 7 to 24 days after infarction. The rats were treated with intraperitoneal injections of 12.5 mg.kg-1.d-1 cyclosporine. In the second protocol, fragments of cultured fetal rat ventricles were injected into the scar 9 to 17 days after infarction. A third group of animals with myocardial infarction was treated with injection of saline into the scar (control). After 7 to 65 days post-transplantation, hearts were harvested and processed for electron microscopy and alpha-actin immunohistochemistry. Toluidine blue staining and electron microscopy revealed the presence of engrafted human and rat cardiomyocytes in the infarcted myocardium up to 14 and 65 days after transplantation, respectively. The morphology was similar to that of cultured fetal cardiomyocytes. The engrafted fetal tissues were also stained positive for alpha-actin, which is unusual for the adult rat myocardium. Examination of control hearts detected infarcted tissue only, and alpha-actin staining was limited to vessel walls.
Conclusions: Fetal cardiomyocyte tissue can be implanted and survive in the infarcted myocardium. This experimental approach may provide a therapeutic strategy for cardiomyocyte-based gene therapy for introduction of therapeutic proteins into myocardial infarction.
Similar articles
-
[Transplantation of fetal cardiomyocyte regenerates infarcted myocardium in rats].Zhonghua Yi Xue Za Zhi. 2003 Oct 25;83(20):1818-22. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14642091 Chinese.
-
Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, and location of expression.J Mol Cell Cardiol. 1996 Oct;28(10):2057-67. doi: 10.1006/jmcc.1996.0199. J Mol Cell Cardiol. 1996. PMID: 8930802
-
Can grafted cardiomyocytes colonize peri-infarct myocardial areas?Circulation. 1996 Nov 1;94(9 Suppl):II337-40. Circulation. 1996. PMID: 8901771
-
Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):784-97. doi: 10.1016/j.addr.2010.03.001. Epub 2010 Mar 6. Adv Drug Deliv Rev. 2010. PMID: 20214939 Review.
-
Protocols for myocardial infarction repair using fetal cardiac myocytes.Methods Mol Med. 2005;112:205-21. doi: 10.1385/1-59259-879-x:205. Methods Mol Med. 2005. PMID: 16010019 Review.
Cited by
-
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.Stem Cell Res Ther. 2023 Sep 23;14(1):264. doi: 10.1186/s13287-023-03495-1. Stem Cell Res Ther. 2023. PMID: 37740221 Free PMC article. Clinical Trial.
-
Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro.PLoS Biol. 2005 Apr;3(4):e87. doi: 10.1371/journal.pbio.0030087. Epub 2005 Mar 15. PLoS Biol. 2005. PMID: 15757365 Free PMC article.
-
Gene therapy for myocardial angiogenesis: with direct intramuscular gene transfer of naked deoxyribonucleic acid encoding vascular endothelial growth factor and cell transplantation of vascular endothelial growth factor transfected H9c2 myoblast.Jpn J Thorac Cardiovasc Surg. 2003 May;51(5):192-7. doi: 10.1007/s11748-003-0030-7. Jpn J Thorac Cardiovasc Surg. 2003. PMID: 12776950
-
An update on stem cell therapies for acute coronary syndrome.Curr Cardiol Rep. 2014 Sep;16(9):526. doi: 10.1007/s11886-014-0526-z. Curr Cardiol Rep. 2014. PMID: 25073868 Review.
-
Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.Tissue Eng Part A. 2011 Mar;17(5-6):585-96. doi: 10.1089/ten.TEA.2010.0259. Epub 2011 Jan 16. Tissue Eng Part A. 2011. PMID: 20868205 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical